Trial design: The effect of high-dose rosuvastatin on echocardiographic parameters in patients with intermediate- and high-risk pulmonary embolism – A randomized placebo-controlled trial

Trial design: The effect of high-dose rosuvastatin on echocardiographic parameters in patients with intermediate- and high-risk pulmonary embolism – A randomized placebo-controlled trial

Background: It has been shown recently that a considerable burden of pulmonary embolism (PE) roots from an inflammatory response. The activated inflammatory cascade will be responsible for the final fibrotic response of pulmonary vascular bed, creating further mechanical obstruction which results in...

Full description

Bibliographic Details
Main Authors: Azin Alizadeh Asl, Mohamad Mehdi Peighambari, Jamal Moosavi, Omid Shafe, Moona Naghshbandi, Melody Farrashi, Nakisa Khansary, Hamid Reza Pouraliakbar, Kiara Rezaei Kalantari, Hooman Bakhshandeh, Hamed Talakoob, Maryam Mohseni Salehi, Sajjad Naderi, Ehsan Ghourchian, Farzaneh Mehrvarz, Nahid Rafiee, Parham Sadeghipour
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Research in Cardiovascular Medicine
Subjects:
Echocardiography
high-intensity statin
pulmonary embolism
right ventricular function
rosuvastatin
Online Access:http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2019;volume=8;issue=1;spage=29;epage=34;aulast=Asl

Internet

http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2019;volume=8;issue=1;spage=29;epage=34;aulast=Asl

Similar Items